Recombinant Human MAP Kinase Activating Death Domain Protein (MADD), Unconjugated

Produktübersicht

• Artikelname: Recombinant Human MAP Kinase Activating Death Domain Protein (MADD), Unconjugated
• Artikelnummer: BIM-RPU58198
• Hersteller Artikelnummer: RPU58198
• Alternativnummer: BIM-RPU58198-50UG, BIM-RPU58198-100UG, BIM-RPU58198-1MG
• Hersteller: Biomatik Corporation
• Kategorie: Proteine/Peptide
• Applikation: Control, SDS-PAGE, WB
• Spezies Reaktivität: Human
• Konjugation: Unconjugated
• Alternative Synonym: DENN, IG20, RAB3GEP, Differentially expressed in normal and neoplastic cells, Insulinoma glucagonoma clone 20, Rab3 GDP/GTP exchange factor

Produktbeschreibung

Recombinant Human MAP Kinase Activating Death Domain Protein (MADD) is a purified Prokaryotic Protein. Purity: >90% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: MAP Kinase Act

Produkteigenschaften

• Molekulargewicht: 34kDa
• Tag: N-terminal His Tag
• NCBI: 8567
• Puffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
• Expression System: Prokaryotic Expression
• Reinheit: >90% by SDS-PAGE
• Formulierung: Freeze-Dried Powder
• Target-Kategorie: MAP Kinase Activating Death Domain Protein (MADD)